Twilight Dark-Adaptation Device Now Available in US - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Twilight Dark-Adaptation Device Now Available in US

Evoq Technologies receives official FDA registration as a Class I medical device

  • By

  • mdspire news news staff

  • December 1, 2025

  • 1 min

Share

  • 1

    Evoq Technologies has received FDA registration for its Twilight dark-adaptation testing instrument as a Class I medical device.

  • 2

    Twilight is designed to detect age-related macular degeneration, diabetic eye disease, and inherited retinal disease.

  • 3

    The device allows technicians to screen for eye diseases without requiring dark rooms or pupil dilation.

  • 4

    Testing with Twilight is reimbursable under CPT 92284 for eligible patients.

  • 5

    Daniel Lindgren, CEO of Evoq Technologies, claims Twilight changes the diagnostic standard of care for eye diseases.

Original Source(s)

Twilight Dark-Adaptation Device Now Available in US

  • by mdspire news news staff

  • December 1, 2025

Related Content

ASRS President Reflects on a Year of Change

As his term comes to a close, Geoffrey G. Emerson, MD, PhD, FASRS, discusses scientific advances, physician advocacy, and the collaborative leadership behind ASRS.

Are GLP-1s Linked to Optic Neuropathy?

A nationwide Swedish cohort found a higher relative risk of anterior ischemic optic neuropathy among GLP-1 receptor agonist users, but the overall risks were low.

Diagnosis Gaps Mark Retinopathy Care

A US systematic review found substantial losses across diabetic retinopathy screening, diagnosis awareness, referral, and follow-up.